These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3788070)

  • 1. [Vasodilator therapy in pulmonary hypertension].
    Widimský J
    Vnitr Lek; 1986 Oct; 32(10):1021-7. PubMed ID: 3788070
    [No Abstract]   [Full Text] [Related]  

  • 2. Vasodilator therapy for pulmonary hypertension.
    Olukotun AY
    N Engl J Med; 1980 May; 302(22):1261-2. PubMed ID: 6154242
    [No Abstract]   [Full Text] [Related]  

  • 3. [Vasodilator therapy in pulmonary arterial hypertension of unknown cause (primary)].
    Lupi Herrera E
    Arch Inst Cardiol Mex; 1982; 52(3):189-90. PubMed ID: 7114962
    [No Abstract]   [Full Text] [Related]  

  • 4. [Vasodilator agents in pulmonary hypertension].
    Farga V
    Rev Med Chil; 1987 Sep; 115(9):902-4. PubMed ID: 3506285
    [No Abstract]   [Full Text] [Related]  

  • 5. [Expectations in the vasodilator treatment of secondary pulmonary hypertension].
    Domenighetti G; Perret C
    Schweiz Med Wochenschr; 1984 Nov; 114(46):1642-4. PubMed ID: 6515365
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vasodilator agents in the treatment of hypertension of the lesser circulation].
    Zaslavskaia RM
    Klin Med (Mosk); 1969 Nov; 47(11):120-6. PubMed ID: 5380020
    [No Abstract]   [Full Text] [Related]  

  • 7. Unpredictable response to vasodilator therapy in primary pulmonary hypertension.
    Schmiedt MI; Shettigar UR; Siddique M; Barbier G; Bialow M; Carranza S
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):435-40. PubMed ID: 9726697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of pulmonary hypertension with vasodilation agents].
    Tschopp JM
    Schweiz Rundsch Med Prax; 1984 Jun; 73(25):789-91. PubMed ID: 6473980
    [No Abstract]   [Full Text] [Related]  

  • 9. Sildenafil in the management of primary pulmonary hypertension.
    Singh B; Gupta R; Punj V; Ghose T; Sapra R; Grover DN; Kaul U
    Indian Heart J; 2002; 54(3):297-300. PubMed ID: 12216929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New indications for sildenafil in sight. Potency drug is potent in pulmonary hypertension].
    MMW Fortschr Med; 2004 Apr; 146(18):8. PubMed ID: 15366459
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary pulmonary hypertension: a therapeutic dilemma.
    Khalilullah M; Bahl VK
    Indian Heart J; 1985; 37(2):75-7. PubMed ID: 4029995
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacological aspects within the scope of pulmonary hypertension].
    Kraupp O
    Med Welt; 1972 Jul; 23(29):1006-8. PubMed ID: 5077680
    [No Abstract]   [Full Text] [Related]  

  • 13. Epoprostenol for primary pulmonary hypertension.
    Med Lett Drugs Ther; 1996 Feb; 38(968):14-5. PubMed ID: 8592477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Some aspects of clinical use of nitric oxide in pulmonary hypertension].
    Cheng X; He J
    Zhonghua Yi Xue Za Zhi; 1998 Jan; 78(1):6-7. PubMed ID: 10923395
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sildenafil in pulmonary hypertension].
    Ewert R; Höper M; Halank M; Winkler J; Wensel R; Opitz C
    Pneumologie; 2003 May; 57(5):291; author reply 291-2; discussion 292. PubMed ID: 12825577
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sildenafil treatment of unilateral pulmonary edema and pulmonary hypertension in pulmonary artery agenesis].
    Rodríguez-Gómez F; Martín I; Sánchez A; Pujol E
    Rev Esp Cardiol; 2006 Dec; 59(12):1347-9. PubMed ID: 17194435
    [No Abstract]   [Full Text] [Related]  

  • 17. [Primary pulmonary hypertension. Treatment with prostacyclin I2 (epoprostenol)].
    Vicente R; Ramos F; Morales P
    Rev Esp Anestesiol Reanim; 1999; 46(6):274. PubMed ID: 10439652
    [No Abstract]   [Full Text] [Related]  

  • 18. [Individual approach to vasodilator treatment of pulmonary hypertension in chronic bronchitis].
    Volkova LI; Shteĭngart IuN
    Klin Med (Mosk); 1994; 72(6):66-7. PubMed ID: 7898022
    [No Abstract]   [Full Text] [Related]  

  • 19. Potentiating the pulmonary vasodilatory effects produced by sildenafil.
    Dias-Junior CA
    Respir Med; 2007 May; 101(5):1041; author reply 1042. PubMed ID: 17321734
    [No Abstract]   [Full Text] [Related]  

  • 20. Sildenafil in neonatal pulmonary hypertension due to impaired alveolarisation and plexiform pulmonary arteriopathy.
    Chaudhari M; Vogel M; Wright C; Smith J; Haworth SG
    Arch Dis Child Fetal Neonatal Ed; 2005 Nov; 90(6):F527-8. PubMed ID: 16244212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.